The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
T‐Cell‐Mimicking Nanoparticles Can Neutralize HIV Infectivity
Open accessAbstract
To improve human immunodeficiency virus (HIV) treatment and prevention, therapeutic strategies that can provide effective and broad‐spectrum neutralization against viral infection are highly desirable. Inspired by recent advances of cell‐membrane coating technology, herein, plasma membranes of CD4+ T cells are collected and coated onto polymeric cores. The resulting T‐cell‐membrane‐coated nanoparticles (denoted as “TNPs”) inherit T cell surface antigens critical for HIV binding, such as CD4 receptor and CCR5 or CXCR4 coreceptors. The TNPs act as decoys for viral attack and neutralize HIV by diverting the viruses away from their intended host targets. This decoy strategy, which simulates host cell functions for viral neutralization rather than directly suppressing viral replication machinery, has the potential to overcome HIV genetic diversity while not eliciting high selective pressure. In this study, it is demonstrated that TNPs selectively bind with gp120, a key envelope glycoprotein of HIV, and inhibit gp120‐induced killing of bystander CD4+ T cells. Furthermore, when added to HIV viruses, TNPs effectively neutralize the viral infection of peripheral mononuclear blood cells and human‐monocyte‐derived macrophages in a dose‐dependent manner. Overall, by leveraging natural T cell functions, TNPs show great potential as a new therapeutic agent against HIV infection.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Finzi, D., Blankson, J., Siliciano, J. D., Margolick, J. B., Chadwick, K., Pierson, T., Smith, K., Lisziewicz, J., Lori, F., Flexner, C., et al. (1999) · Nature Medicine · doi:10.1038/8394 · Cited by 2,119
Cell Membrane Coating Nanotechnology
Fang, R. H., Kroll, A. V., Gao, W., & Zhang, L. (2018) · Advanced Materials · doi:10.1002/adma.201706759 · Cited by 1,885
Self-citationHIV-1 assembly, release and maturation
Freed, E. O. (2015) · Nature Reviews Microbiology · doi:10.1038/nrmicro3490 · Cited by 654
HIV-1 capsid: the multifaceted key player in HIV-1 infection
Campbell, E. M., & Hope, T. J. (2015) · Nature Reviews Microbiology · doi:10.1038/nrmicro3503 · Cited by 430
Cited by
Cell Membrane Coating Technology: A Promising Strategy for Biomedical Applications
Liu, Y., Luo, J., Chen, X., Liu, W., & Chen, T. (2019) · Nano-Micro Letters · doi:10.1007/s40820-019-0330-9 · Cited by 408
Feng, X., Xu, W., Li, Z., Song, W., Ding, J., & Chen, X. (2019) · Advanced Science · doi:10.1002/advs.201900101 · Cited by 363
Cellular Nanosponges Inhibit SARS-CoV-2 Infectivity
Zhang, Q., Honko, A., Zhou, J., Gong, H., Downs, S. N., Vasquez, J. H., Fang, R. H., Gao, W., Griffiths, A., & Zhang, L. (2020) · Nano Letters · doi:10.1021/acs.nanolett.0c02278 · Cited by 346
Self-citationYin, C., Zhao, Q., Li, W., Zhao, Z., Wang, J., Deng, T., Zhang, P., Shen, K., Li, Z., & Zhang, Y. (2020) · Acta Biomaterialia · doi:10.1016/j.actbio.2019.11.025 · Cited by 143
Yang, K.-C., Lin, J.-C., Tsai, H.-H., Hsu, C.-Y., Shih, V., & Hu, C.-M. J. (2021) · Drug Delivery and Translational Research · doi:10.1007/s13346-021-00965-y · Cited by 39
Metadata
- Authors
- Wei, X., Zhang, G., Ran, D., Krishnan, N., Fang, R. H., Gao, W., Spector, S. A., & Zhang, L.
- Venue
- Advanced Materials
- Publisher
- Wiley
- Published
- 2018-09-25
- Volume
- 30
- Issue
- 45
- Pages
- e1802233-e1802233
- ISSN
- 0935-9648 (ISSN-L)
- 1521-4095
- OpenAlex
- W2893380545
- Cited by
- 201
- References
- 4
- FWCI
- 11.49
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: T‐Cell‐Mimicking Nanoparticles Can Neutralize HIV Infectivity. https://app.cochat.ai/papers/10.1002/adma.201802233
- The paper
- Wei, X., Zhang, G., Ran, D., Krishnan, N., Fang, R. H., Gao, W., Spector, S. A., & Zhang, L. (2018). T‐Cell‐Mimicking Nanoparticles Can Neutralize HIV Infectivity. Advanced Materials. https://doi.org/10.1002/adma.201802233
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.